Today: 12 May 2026
BAE Systems stock jumps toward 2,100p as Sweden flags new air-defence spending
12 January 2026
1 min read

BAE Systems stock jumps toward 2,100p as Sweden flags new air-defence spending

London, 12 January 2026, 08:10 GMT — Regular session

  • BAE Systems shares climbed roughly 2% in early London trading, briefly hitting a 52-week peak
  • Sweden announced a 15 billion crown investment in air-defence systems, boosting momentum in the sector
  • Investors are turning to BAE’s February results for clues on guidance and cash returns

Shares of BAE Systems (BAES.L) climbed in early London trading on Monday, briefly hitting 2,098 pence—their 52-week peak. By 0810 GMT, the stock was trading around 2,095 pence, up roughly 2%.

The UK defence group remains on a strong streak heading into mid-January. Its shares have jumped about 20% since closing on Dec. 31, as investors favor contractors tied to government spending over those dependent on consumer demand.

Sweden gave the budget narrative a push this weekend, announcing a 15 billion Swedish crown ($1.6 billion) investment in air-defence systems. Defence Minister Pal Jonson pointed to the Ukraine conflict, saying, “The experience from the war in Ukraine clearly shows how crucial a robust and resilient air defence is.” Reuters

BAE last pointed to a supportive environment but hasn’t updated investors this month. In its November trading statement, the firm reaffirmed its 2025 targets: 8% to 10% sales growth and 9% to 11% growth in underlying EBIT. It also forecast free cash flow exceeding £1.1 billion. The company expects to return about £1.5 billion to shareholders in 2025, including roughly £500 million in share buybacks. Preliminary results are slated for Feb. 18.

Chief executive Charles Woodburn said at the time the firm was “confident in the outlook,” pointing to a strong order backlog and “continued investment to support our future growth.” For investors, that backlog means work already contracted but still pending delivery.

European peers like Saab, Rheinmetall, and Leonardo have surged in this trade, driven by strong demand for air defence and munitions. For many funds, the sector now serves as a go-to “geopolitics hedge,” even when general equity appetite wanes.

Traders are expected to focus more on order flow than headlines alone. While large budget announcements hit the news fast, it’s the timing of contracts, delivery schedules, and shifts in programmes that actually determine when revenue arrives.

But with shares pushing near the top of their recent range, there’s little margin for error. A slowdown in contract awards, production hiccups, or weaker cash conversion could quickly weigh on the stock.

Macro noise added to the jitters Monday as Federal Reserve Chair Jerome Powell revealed the Trump administration threatened him with a criminal indictment, sparking fresh concerns over central bank independence. “Trump is pulling at the loose threads of central bank independence,” said Andrew Lilley at Barrenjoey. U.S. inflation figures and the kickoff of big-bank earnings this week could shift risk appetite sharply. Reuters

Stock Market Today

  • HSIC Posts Robust Q1 2026 Sales and Margin Gains Driven by U.S. Dental, Technology Units
    May 12, 2026, 12:09 PM EDT. Henry Schein Inc. (HSIC) delivered strong sales and margin growth in the first quarter of 2026. The U.S. Dental segment led the rise, supported by solid performance in technology divisions. These gains highlight continued demand in healthcare supply and technology services, underpinning HSIC's solid market position. Investors will watch upcoming earnings for further details on segment contributions and outlook amid evolving healthcare needs.

Latest article

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

12 May 2026
Hims & Hers Health shares fell 14.6% to $24.89 Tuesday after a Q1 net loss of $92.1 million, reversing a $49.5 million profit a year ago. Revenue rose 4% to $608.1 million, but gross margin dropped to 65% from 73% as the company shifted from compounded GLP-1s to branded drugs like Wegovy and Ozempic. Subscribers climbed to 2.584 million, while monthly revenue per subscriber slipped to $80.
POET Stock Rebounds as New COO Gives AI-Photonics Rally a Fresh Test

POET Stock Rebounds as New COO Gives AI-Photonics Rally a Fresh Test

12 May 2026
POET Technologies named Sandeep Kumar as chief operating officer, triggering a 2.95% stock rise to $14.31 on heavy volume after shares hit $15.15 intraday. Kumar, formerly of Silicon Labs, will oversee Malaysia manufacturing as the company targets high-volume production. The move comes after Marvell canceled Celestial AI orders, which had weighed on the stock. Broader tech indices fell Tuesday, but POET shares outperformed.
IREN Stock Slips as Nvidia Deal Runs Into the Price of Building AI Capacity

IREN Stock Slips as Nvidia Deal Runs Into the Price of Building AI Capacity

12 May 2026
IREN shares fell about 2.4% to $53.80 Tuesday after the company priced an upsized $2.6 billion convertible-note sale, raising concerns over funding costs and dilution. The notes carry a 1% coupon and can convert at $73.07 per share. IREN reported a $247.8 million net loss last quarter. Peers Cipher Digital, Riot Platforms, and Marathon Digital also traded lower.

Popular

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

24 October 2025
Theriva shares surged 92% intraday Oct. 15 after its VCN-01 therapy met primary endpoints in a Phase 2b pancreatic cancer trial, then fell back following a $4 million equity raise. Median survival in a two-dose subgroup reached 14.8 months versus 11.6 for chemo alone. The company held $12.1 million cash as of June 30, 2025, funding operations into early 2026. Expanded trial results will be presented at ESMO Oct. 20.
Yangzijiang Financial (YF8) stock ticks up in Singapore as U.S. CPI and Fed tensions loom
Previous Story

Yangzijiang Financial (YF8) stock ticks up in Singapore as U.S. CPI and Fed tensions loom

Babcock (BAB.L) share price edges toward 52-week high as traders line up for Jan 26 update
Next Story

Babcock (BAB.L) share price edges toward 52-week high as traders line up for Jan 26 update

Go toTop